{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:11:05Z","timestamp":1792080665422,"version":"4.4.0"},"reference-count":151,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["14-25-00024-\u041f"],"award-info":[{"award-number":["14-25-00024-\u041f"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["17.991.2017\/\u041f\u0427"],"award-info":[{"award-number":["17.991.2017\/\u041f\u0427"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011051","name":"Council on grants of the President of the Russian Federation","doi-asserted-by":"publisher","award":["EP"],"award-info":[{"award-number":["EP"]}],"id":[{"id":"10.13039\/501100011051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011051","name":"Council on grants of the President of the Russian Federation","doi-asserted-by":"publisher","award":["14.Y30.17.1043-MK"],"award-info":[{"award-number":["14.Y30.17.1043-MK"]}],"id":[{"id":"10.13039\/501100011051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Calcium"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ceca.2017.06.008","type":"journal-article","created":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T01:16:27Z","timestamp":1498785387000},"page":"87-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":338,"special_numbering":"C","title":["Calcium signaling and molecular mechanisms underlying neurodegenerative diseases"],"prefix":"10.1016","volume":"70","author":[{"given":"Ekaterina","family":"Pchitskaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Popugaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Bezprozvanny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ceca.2017.06.008_bib0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-3-319-26974-0_7","article-title":"Extracellular calcium has multiple targets to control cell proliferation","volume":"898","author":"Capiod","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ceca.2017.06.008_bib0010","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.cell.2007.11.028","article-title":"Calcium signaling","volume":"131","author":"Clapham","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ceca.2017.06.008_bib0015","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ceca.2016.04.005","article-title":"Intracellular Ca(2+) signaling and Ca(2+) microdomains in the control of cell survival, apoptosis and autophagy","volume":"60","author":"La Rovere","year":"2016","journal-title":"Cell Calcium"},{"key":"10.1016\/j.ceca.2017.06.008_bib0020","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ceca.2016.02.011","article-title":"Regulation of neurogenesis by calcium signaling","volume":"59","author":"Toth","year":"2016","journal-title":"Cell Calcium"},{"key":"10.1016\/j.ceca.2017.06.008_bib0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(00)80510-3","article-title":"Neuronal calcium signaling","volume":"21","author":"Berridge","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.ceca.2017.06.008_bib0030","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1007\/s00018-013-1550-7","article-title":"Neuronal calcium signaling: function and dysfunction","volume":"71","author":"Brini","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0035","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1042\/bj3570673","article-title":"Identification and characterization of the STIM (stromal interaction molecule) gene family: coding for a novel class of transmembrane proteins","volume":"357","author":"Williams","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.ceca.2017.06.008_bib0040","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2007.11.039","article-title":"STIM2 is a feedback regulator that stabilizes basal cytosolic and endoplasmic reticulum Ca2+ levels","volume":"131","author":"Brandman","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ceca.2017.06.008_bib0045","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/19336950.2015.1071747","article-title":"STIM and ORAI proteins in the nervous system","volume":"9","author":"Kraft","year":"2015","journal-title":"Channels"},{"key":"10.1016\/j.ceca.2017.06.008_bib0050","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrm3414","article-title":"STIM proteins: dynamic calcium signal transducers","volume":"13","author":"Soboloff","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ceca.2017.06.008_bib0055","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.bbamcr.2015.01.019","article-title":"SOCE in neurons: signaling or just refilling?","volume":"1853","author":"Majewski","year":"2015","journal-title":"Biochim. et Biophys. Acta (BBA) Mol. Cell Res."},{"key":"10.1016\/j.ceca.2017.06.008_bib0060","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1152\/physrev.00057.2003","article-title":"Store-operated calcium channels","volume":"85","author":"Parekh","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ceca.2017.06.008_bib0065","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/ncb1590","article-title":"STIM1 heteromultimerizes TRPC channels to determine their function as store-operated channels","volume":"9","author":"Yuan","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ceca.2017.06.008_bib0070","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1073\/pnas.0712288105","article-title":"Functional interactions among Orai1, TRPCs, and STIM1 suggest a STIM-regulated heteromeric Orai\/TRPC model for SOCE\/Icrac channels","volume":"105","author":"Liao","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ceca.2017.06.008_bib0075","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1073\/pnas.0813346106","article-title":"A role for Orai in TRPC-mediated Ca(2+) entry suggests that a TRPC: Orai complex may mediate store and receptor operated Ca(2+) entry","volume":"106","author":"Liao","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ceca.2017.06.008_bib0080","doi-asserted-by":"crossref","first-page":"11837","DOI":"10.1523\/JNEUROSCI.1188-16.2016","article-title":"Store-operated calcium channel complex in postsynaptic spines: a new therapeutic target for Alzheimer's disease treatment","volume":"36","author":"Zhang","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0085","doi-asserted-by":"crossref","DOI":"10.1007\/978-94-007-0265-3_24","article-title":"Contribution of TRPC1 and Orai1 to Ca(2+) entry activated by store depletion","volume":"704","author":"Chen","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ceca.2017.06.008_bib0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/neuro.24.002.2009","article-title":"Susceptibility to calcium dysregulation during brain aging","volume":"1","author":"Kumar","year":"2009","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.molmed.2009.01.001","article-title":"Calcium signaling and neurodegenerative diseases","volume":"15","author":"Bezprozvanny","year":"2009","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ceca.2017.06.008_bib0100","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3390\/ijms18030551","article-title":"Parkinson\u2019s disease: from pathogenesis to pharmacogenomics","volume":"18","author":"Cacabelos","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13195-016-0207-9","article-title":"Drug development in Alzheimer\u2019s disease: the path to 2025","volume":"8","author":"Cummings","year":"2016","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.ceca.2017.06.008_bib0110","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1517\/14656566.2016.1109630","article-title":"Advancing pharmacotherapy for treating Huntington's disease: a review of the existing literature","volume":"17","author":"Mason","year":"2016","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ceca.2017.06.008_bib0115","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ceca.2017.06.008_bib0120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1474-4422(09)70332-1","article-title":"Gamma-secretases: from cell biology to therapeutic strategies","volume":"9","author":"Bergmans","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ceca.2017.06.008_bib0125","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1471-4159.2009.06181.x","article-title":"The amyloid hypothesis for Alzheimer's disease: a critical reappraisal","volume":"110","author":"Hardy","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ceca.2017.06.008_bib0130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000197890","article-title":"Significance of brain lesions in Parkinson disease dementia and Lewy body dementia","volume":"24","author":"Jellinger","year":"2009","journal-title":"Front Neurol. Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0135","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s40572-017-0143-2","article-title":"Mechanisms of gene-environment interactions in Parkinson's disease","volume":"4","author":"Fleming","year":"2017","journal-title":"Curr. Environ. Health Rep."},{"key":"10.1016\/j.ceca.2017.06.008_bib0140","doi-asserted-by":"crossref","DOI":"10.1186\/alzrt269","article-title":"Alzheimer\u2019s disease drug-development pipeline: few candidates, frequent failures","volume":"6","author":"Cummings","year":"2014","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.ceca.2017.06.008_bib0145","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ana.24188","article-title":"A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease","volume":"76","author":"Karran","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ceca.2017.06.008_bib0150","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics","volume":"10","author":"Karran","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ceca.2017.06.008_bib0155","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jalz.2016.12.006","article-title":"Calcium Hypothesis of Alzheimer's disease and brain aging: a framework for integrating new evidence into a comprehensive theory of pathogenesis","volume":"13","author":"Alzheimer's Association Calcium Hypothesis","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ceca.2017.06.008_bib0160","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tins.2008.06.005","article-title":"Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease","volume":"31","author":"Bezprozvanny","year":"2008","journal-title":"Trends Neurosci."},{"issue":"4","key":"10.1016\/j.ceca.2017.06.008_bib0165","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.bbrc.2016.09.088","article-title":"Emerging pathways driving early synaptic pathology in Alzheimer's disease","volume":"483","author":"Briggs","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ceca.2017.06.008_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1989.tb12485.x","article-title":"Calcium, membranes, aging, and Alzheimer's disease. Introduction and overview","volume":"568","author":"Khachaturian","year":"1989","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0175","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s11064-010-0371-4","article-title":"Calcium signalling and Alzheimer's disease","volume":"36","author":"Berridge","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ceca.2017.06.008_bib0180","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1750-1326-8-23","article-title":"The synaptic maintenance problem: membrane recycling, Ca2+ homeostasis and late onset degeneration","volume":"8","author":"Bezprozvanny","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ceca.2017.06.008_bib0185","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.bbrc.2016.09.053","article-title":"Dysregulation of neuronal calcium homeostasis in Alzheimer's disease \u2013 a therapeutic opportunity?","volume":"483","author":"Popugaeva","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ceca.2017.06.008_bib0190","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/j.bbamem.2007.03.014","article-title":"Abeta ion channels. Prospects for treating Alzheimer's disease with Abeta channel blockers","volume":"1768","author":"Arispe","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ceca.2017.06.008_bib0195","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1073\/pnas.90.2.567","article-title":"Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum","volume":"90","author":"Arispe","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ceca.2017.06.008_bib0200","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neuron.2008.06.008","article-title":"Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks","volume":"59","author":"Kuchibhotla","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.ceca.2017.06.008_bib0205","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1471-4159.1997.68010265.x","article-title":"Amyloid beta protein potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels: a possible involvement of free radicals","volume":"68","author":"Ueda","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ceca.2017.06.008_bib0210","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1523\/JNEUROSCI.4771-07.2008","article-title":"Amyloid beta oligomers (A beta(1\u201342) globulomer) suppress spontaneous synaptic activity by inhibition of P\/Q-type calcium currents","volume":"28","author":"Nimmrich","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0215","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0220","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbr.2016.05.012","article-title":"Central role for NMDA receptors in redox mediated impairment of synaptic function during aging and Alzheimer's disease","volume":"322","author":"Foster","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"Pt A","key":"10.1016\/j.ceca.2017.06.008_bib0225","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2013.08.013","article-title":"Dysfunctional synapse in Alzheimer's disease \u2013 a focus on NMDA receptors","volume":"76","author":"Mota","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ceca.2017.06.008_bib0230","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.expneurol.2007.10.008","article-title":"Amyloid beta peptides and glutamatergic synaptic dysregulation","volume":"210","author":"Parameshwaran","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ceca.2017.06.008_bib0235","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s10072-016-2546-5","article-title":"Dysfunction of NMDA receptors in Alzheimer\u2019s disease","volume":"37","author":"Zhang","year":"2016","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0240","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ceca.2011.11.008","article-title":"Amyloid beta peptide 1\u201342 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures","volume":"51","author":"Ferreira","year":"2012","journal-title":"Cell Calcium"},{"key":"10.1016\/j.ceca.2017.06.008_bib0245","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrd1958","article-title":"Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond","volume":"5","author":"Lipton","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"Part A","key":"10.1016\/j.ceca.2017.06.008_bib0250","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2013.08.013","article-title":"Dysfunctional synapse in Alzheimer's disease \u2013 a focus on NMDA receptors","volume":"76","author":"Mota","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ceca.2017.06.008_bib0255","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrn2229","article-title":"Pathologically activated therapeutics for neuroprotection","volume":"8","author":"Lipton","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0260","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nn1503","article-title":"Regulation of NMDA receptor trafficking by amyloid-[beta]","volume":"8","author":"Snyder","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0265","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3233\/JAD-2007-11113","article-title":"Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease","volume":"11","author":"Jacob","year":"2007","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ceca.2017.06.008_bib0270","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1471-4159.2003.02330.x","article-title":"Selective loss of NMDA receptor NR1 subunit isoforms in Alzheimer's disease","volume":"89","author":"Hynd","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ceca.2017.06.008_bib0275","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1074\/jbc.M607483200","article-title":"Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine","volume":"282","author":"De Felice","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2017.06.008_bib0280","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","article-title":"Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease","volume":"27","author":"Lacor","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0285","doi-asserted-by":"crossref","first-page":"11532","DOI":"10.1523\/JNEUROSCI.1603-16.2016","article-title":"Local and use-dependent effects of beta-amyloid oligomers on NMDA receptor function revealed by optical quantal analysis","volume":"36","author":"Sinnen","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0290","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ceca.2011.02.001","article-title":"Amyloid beta peptide oligomers directly activate NMDA receptors","volume":"49","author":"Texido","year":"2011","journal-title":"Cell Calcium"},{"key":"10.1016\/j.ceca.2017.06.008_bib0295","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1073\/pnas.91.2.534","article-title":"Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease","volume":"91","author":"Ito","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ceca.2017.06.008_bib0300","doi-asserted-by":"crossref","first-page":"32535","DOI":"10.1074\/jbc.274.46.32535","article-title":"Presenilin-2 mutations modulate amplitude and kinetics of inositol 1, 4,5-trisphosphate-mediated calcium signals","volume":"274","author":"Leissring","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2017.06.008_bib0305","first-page":"1061","article-title":"Alzheimer's presenilin-1 mutation potentiates inositol 1,4,5-trisphosphate-mediated calcium signaling in Xenopus oocytes","volume":"72","author":"Leissring","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ceca.2017.06.008_bib0310","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1172\/JCI30447","article-title":"Familial Alzheimer disease\u2013linked mutations specifically disrupt Ca(2+) leak function of presenilin 1","volume":"117","author":"Nelson","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ceca.2017.06.008_bib0315","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1523\/JNEUROSCI.4386-03.2004","article-title":"Dysregulated IP3 signaling in cortical neurons of knock-in mice expressing an Alzheimer's-linked mutation in presenilin1 results in exaggerated Ca2+ signals and altered membrane excitability","volume":"24","author":"Stutzmann","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0320","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1523\/JNEUROSCI.0739-06.2006","article-title":"Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice","volume":"26","author":"Stutzmann","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0325","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.cell.2006.06.059","article-title":"Presenilins form ER Ca(2+) leak channels, a function disrupted by familial alzheimer's disease-linked mutations","volume":"126","author":"Tu","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ceca.2017.06.008_bib0330","doi-asserted-by":"crossref","first-page":"16649","DOI":"10.1074\/jbc.M512026200","article-title":"The presenilin-2 loop peptide perturbs intracellular Ca2+ homeostasis and accelerates apoptosis","volume":"281","author":"Cai","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2017.06.008_bib0335","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2000818","article-title":"Gain-of-function enhancement of IP3 receptor modal gating by familial Alzheimer's disease-linked presenilin mutants in human cells and mouse neurons","author":"Cheung","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ceca.2017.06.008_bib0340","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.neuron.2008.04.015","article-title":"Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP(3) receptor channel gating","volume":"58","author":"Cheung","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.ceca.2017.06.008_bib0345","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1083\/jcb.149.4.793","article-title":"Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice","volume":"149","author":"Leissring","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ceca.2017.06.008_bib0350","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0896-6273(00)00066-0","article-title":"Presenilin-mediated modulation of capacitative calcium entry","volume":"27","author":"Yoo","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.ceca.2017.06.008_bib0355","doi-asserted-by":"crossref","first-page":"18195","DOI":"10.1074\/jbc.M000040200","article-title":"Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons","volume":"275","author":"Chan","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2017.06.008_bib0360","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ceca.2008.03.004","article-title":"The N-terminus of presenilin-2 increases single channel activity of brain ryanodine receptors through direct protein-protein interaction","volume":"44","author":"Hayrapetyan","year":"2008","journal-title":"Cell Calcium"},{"key":"10.1016\/j.ceca.2017.06.008_bib0365","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.biocel.2007.06.023","article-title":"The cytosolic N-terminus of presenilin-1 potentiates mouse ryanodine receptor single channel activity","volume":"40","author":"Rybalchenko","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ceca.2017.06.008_bib0370","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1083\/jcb.200706171","article-title":"SERCA pump activity is physiologically regulated by presenilin and regulates amyloid beta production","volume":"181","author":"Green","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ceca.2017.06.008_bib0375","doi-asserted-by":"crossref","first-page":"22339","DOI":"10.1074\/jbc.M111.243063","article-title":"Mutagenesis mapping of the presenilin 1 calcium leak conductance pore","volume":"286","author":"Nelson","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2017.06.008_bib0380","doi-asserted-by":"crossref","first-page":"8566","DOI":"10.1523\/JNEUROSCI.1554-10.2010","article-title":"Role of presenilins in neuronal calcium homeostasis","volume":"30","author":"Zhang","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0385","doi-asserted-by":"crossref","first-page":"10933","DOI":"10.1074\/jbc.M111.300491","article-title":"Lack of evidence for presenilins as endoplasmic reticulum Ca2+ leak channels","volume":"287","author":"Shilling","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2017.06.008_bib0390","doi-asserted-by":"crossref","first-page":"ra56","DOI":"10.1126\/scisignal.2003649","article-title":"Regulators of calcium homeostasis identified by inference of kinetic model parameters from live single cells perturbed by siRNA","volume":"6","author":"Bandara","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ceca.2017.06.008_bib0395","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/pro.2919","article-title":"Presenilin adopts the ClC channel fold","volume":"25","author":"Theobald","year":"2016","journal-title":"Protein Sci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0400","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature11801","article-title":"Structure of a presenilin family intramembrane aspartate protease","volume":"493","author":"Li","year":"2013","journal-title":"Nature"},{"issue":"1001","key":"10.1016\/j.ceca.2017.06.008_bib0405","first-page":"e1001","article-title":"Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease","volume":"33","author":"Bruno","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ceca.2017.06.008_bib0410","doi-asserted-by":"crossref","first-page":"8341","DOI":"10.1523\/JNEUROSCI.0936-12.2012","article-title":"Early presynaptic and postsynaptic calcium signaling abnormalities mask underlying synaptic depression in presymptomatic Alzheimer's disease mice","volume":"32","author":"Chakroborty","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0415","doi-asserted-by":"crossref","first-page":"12128","DOI":"10.1523\/JNEUROSCI.2474-10.2010","article-title":"NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice","volume":"30","author":"Goussakov","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0420","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3233\/JAD-142427","article-title":"Calcium signaling, excitability, and synaptic plasticity defects in a mouse model of Alzheimer's disease","volume":"45","author":"Zhang","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ceca.2017.06.008_bib0425","doi-asserted-by":"crossref","first-page":"e52056","DOI":"10.1371\/journal.pone.0052056","article-title":"Stabilizing ER Ca2+ channel function as an early preventative strategy for Alzheimer's disease","volume":"7","author":"Chakroborty","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ceca.2017.06.008_bib0430","doi-asserted-by":"crossref","first-page":"11820","DOI":"10.1523\/JNEUROSCI.0875-12.2012","article-title":"Ryanodine receptor blockade reduces amyloid-beta load and memory impairments in tg2576 mouse model of Alzheimer disease","volume":"32","author":"Oules","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0435","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.neulet.2012.04.008","article-title":"Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic mice","volume":"516","author":"Peng","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ceca.2017.06.008_bib0440","doi-asserted-by":"crossref","first-page":"8566","DOI":"10.1523\/JNEUROSCI.1554-10.2010","article-title":"Role of presenilins in neuronal calcium homeostasis","volume":"30","author":"Zhang","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0445","doi-asserted-by":"crossref","first-page":"33477","DOI":"10.1074\/jbc.M602306200","article-title":"Azumolene inhibits a component of store-operated calcium entry coupled to the skeletal muscle ryanodine receptor","volume":"281","author":"Zhao","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2017.06.008_bib0450","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","article-title":"Dantrolene-a review of its pharmacology, therapeutic use and new developments","volume":"59","author":"Krause","year":"2004","journal-title":"Anaesthesia"},{"key":"10.1016\/j.ceca.2017.06.008_bib0455","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4161\/chan.27471","article-title":"The role of ryanodine receptor type 3 in a mouse model of Alzheimer disease","volume":"8","author":"Liu","year":"2014","journal-title":"Channels (Austin)"},{"key":"10.1016\/j.ceca.2017.06.008_bib0460","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.bbamcr.2008.11.008","article-title":"Presenilin-dependent expression of STIM proteins and dysregulation of capacitative Ca2+ entry in familial Alzheimer's disease","volume":"1793","author":"Bojarski","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ceca.2017.06.008_bib0465","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuron.2014.02.019","article-title":"Reduced synaptic STIM2 expression and impaired store-operated calcium entry cause destabilization of mature spines in mutant presenilin mice","volume":"82","author":"Sun","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.ceca.2017.06.008_bib0470","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1113\/JP272645","article-title":"The role of the store-operated calcium entry channel Orai1 in cultured rat hippocampal synapse formation and plasticity","volume":"595","author":"Korkotian","year":"2017","journal-title":"J. Physiol."},{"key":"10.1016\/j.ceca.2017.06.008_bib0475","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13024-015-0034-7","article-title":"STIM2 protects hippocampal mushroom spines from amyloid synaptotoxicity","volume":"10","author":"Popugaeva","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ceca.2017.06.008_bib0480","doi-asserted-by":"crossref","first-page":"13275","DOI":"10.1523\/JNEUROSCI.1034-15.2015","article-title":"Neuronal store-operated calcium entry and mushroom spine loss in amyloid precursor protein knock-in mouse model of Alzheimer's disease","volume":"35","author":"Zhang","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0485","doi-asserted-by":"crossref","first-page":"ra89","DOI":"10.1126\/scisignal.aaf1371","article-title":"Familial Alzheimer's disease-associated presenilin 1 mutants promote gamma-secretase cleavage of STIM1 to impair store-operated Ca2+ entry","volume":"9","author":"Tong","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ceca.2017.06.008_bib0490","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"The., Huntington's., Disease., Collaborative., Research., and Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ceca.2017.06.008_bib0495","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","article-title":"A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length","volume":"65","author":"Langbehn","year":"2004","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ceca.2017.06.008_bib0500","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"April (23)","key":"10.1016\/j.ceca.2017.06.008_bib0505","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat Rev Dis Primers."},{"key":"10.1016\/j.ceca.2017.06.008_bib0510","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.bbrc.2016.07.058","article-title":"Striatal synaptic dysfunction and altered calcium regulation in Huntington disease","volume":"483","author":"Raymond","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ceca.2017.06.008_bib0515","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1046\/j.1471-4159.1999.0721890.x","article-title":"Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin","volume":"72","author":"Chen","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ceca.2017.06.008_bib0520","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1523\/JNEUROSCI.4356-06.2007","article-title":"Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington's disease","volume":"27","author":"Fan","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0525","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.ceca.2017.06.008_bib0530","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuron.2010.01.010","article-title":"Location, location, location: contrasting roles of synaptic and extrasynaptic NMDA receptors in Huntington's disease","volume":"65","author":"Levine","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.ceca.2017.06.008_bib0535","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","article-title":"early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice","volume":"65","author":"Milnerwood","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.ceca.2017.06.008_bib0540","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.conb.2015.01.020","article-title":"Corticostriatal synaptic adaptations in Huntington's disease","volume":"33","author":"Plotkin","year":"2015","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.ceca.2017.06.008_bib0545","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/jnc.12700","article-title":"Alterations in STriatal-Enriched protein tyrosine phosphatase expression, activation, and downstream signaling in early and late stages of the YAC128 Huntington's disease mouse model","volume":"130","author":"Gladding","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ceca.2017.06.008_bib0550","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1093\/hmg\/dds154","article-title":"Calpain and STriatal-Enriched protein tyrosine phosphatase (STEP) activation contribute to extrasynaptic NMDA receptor localization in a Huntington's disease mouse model","volume":"21","author":"Gladding","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ceca.2017.06.008_bib0555","first-page":"6","article-title":"Differential synaptic and extrasynaptic glutamate-receptor alterations in striatal medium-sized spiny neurons of aged YAC128 huntington's disease mice","author":"Botelho","year":"2014","journal-title":"PLoS Curr."},{"key":"10.1016\/j.ceca.2017.06.008_bib0560","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neulet.2006.08.036","article-title":"Evaluation of clinically relevant glutamate pathway inhibitors in in vitro model of Huntington's disease","volume":"407","author":"Wu","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ceca.2017.06.008_bib0565","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.nbd.2013.11.013","article-title":"Chronic blockade of extrasynaptic NMDA receptors ameliorates synaptic dysfunction and pro-death signaling in Huntington disease transgenic mice","volume":"62","author":"Dau","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ceca.2017.06.008_bib0570","doi-asserted-by":"crossref","DOI":"10.1038\/nm.2056","article-title":"Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin","author":"Okamoto","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.ceca.2017.06.008_bib0575","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.parkreldis.2006.08.005","article-title":"A pilot study of the clinical efficacy and safety of memantine for Huntington's disease","volume":"13","author":"Ondo","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.ceca.2017.06.008_bib0580","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1371\/journal.pgen.0030082","article-title":"Huntingtin interacting proteins are genetic modifiers of neurodegeneration","volume":"3","author":"Kaltenbach","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ceca.2017.06.008_bib0585","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0896-6273(03)00366-0","article-title":"Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1, 4, 5) triphosphate receptor type 1","volume":"39","author":"Tang","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.ceca.2017.06.008_bib0590","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.mcn.2005.07.016","article-title":"Crosstalk between huntingtin and syntaxin 1A regulates N-type calcium channels","volume":"30","author":"Swayne","year":"2005","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0595","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1523\/JNEUROSCI.4411-08.2009","article-title":"Neuroprotective effects of inositol 1,4,5-trisphosphate receptor C-terminal fragment in a Huntington's disease mouse model","volume":"29","author":"Tang","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0600","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1073\/pnas.0409402102","article-title":"Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease","volume":"102","author":"Tang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ceca.2017.06.008_bib0605","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbrc.2012.10.107","article-title":"Calcium leak through ryanodine receptor is involved in neuronal death induced by mutant huntingtin","volume":"429","author":"Suzuki","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ceca.2017.06.008_bib0610","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1750-1326-6-81","article-title":"Dantrolene is neuroprotective in Huntington's disease transgenic mouse model","volume":"6","author":"Chen","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ceca.2017.06.008_bib0615","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1523\/JNEUROSCI.1038-15.2016","article-title":"Enhanced store-operated calcium entry leads to striatal synaptic loss in a Huntington's disease mouse model","volume":"36","author":"Wu","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0620","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.chembiol.2011.04.012","article-title":"Neuronal store-operated calcium entry pathway as a novel therapeutic target for Huntington's disease treatment","volume":"18","author":"Wu","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ceca.2017.06.008_bib0625","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson's disease","volume":"373","author":"Lees","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ceca.2017.06.008_bib0630","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1055\/s-0031-1299782","article-title":"Genetics of Parkinson's disease","volume":"31","author":"Kumar","year":"2011","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.ceca.2017.06.008_bib0635","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrneurol.2013.132","article-title":"Advances in the genetics of Parkinson disease","volume":"9","author":"Trinh","year":"2013","journal-title":"Nat Rev Neurol."},{"issue":"4","key":"10.1016\/j.ceca.2017.06.008_bib0640","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.bbrc.2016.08.153","article-title":"Emerging (and converging) pathways in Parkinson's disease: keeping mitochondrial wellness","volume":"483","author":"Cieri","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ceca.2017.06.008_bib0645","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00441-014-1866-0","article-title":"Calcium signaling in Parkinson's disease","volume":"357","author":"Cali","year":"2014","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ceca.2017.06.008_bib0650","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1242\/dmm.028738","article-title":"The role of Ca(2+) signaling in Parkinson's disease","volume":"10","author":"Zaichick","year":"2017","journal-title":"Disease Models & Mechanisms."},{"key":"10.1016\/j.ceca.2017.06.008_bib0655","doi-asserted-by":"crossref","first-page":"11011","DOI":"10.1523\/JNEUROSCI.2519-09.2009","article-title":"Robust pacemaking in substantia nigra dopaminergic neurons","volume":"29","author":"Guzman","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0660","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1523\/JNEUROSCI.4341-06.2007","article-title":"Roles of subthreshold calcium current and sodium current in spontaneous firing of mouse midbrain dopamine neurons","volume":"27","author":"Puopolo","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0665","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nature05865","article-title":"\u2018Rejuvenation\u2019 protects neurons in mouse models of Parkinson's disease","volume":"447","author":"Chan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ceca.2017.06.008_bib0670","doi-asserted-by":"crossref","first-page":"a009290","DOI":"10.1101\/cshperspect.a009290","article-title":"Physiological phenotype and vulnerability in Parkinson's disease","volume":"2","author":"Surmeier","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"4","key":"10.1016\/j.ceca.2017.06.008_bib0675","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bbrc.2016.08.168","article-title":"Calcium and Parkinson's disease","volume":"483","author":"Surmeier","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ceca.2017.06.008_bib0680","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.nbd.2011.04.007","article-title":"The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease","volume":"43","author":"Ilijic","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ceca.2017.06.008_bib0685","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1212\/01.wnl.0000303818.38960.44","article-title":"Use of antihypertensives and the risk of Parkinson disease","volume":"70","author":"Becker","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ceca.2017.06.008_bib0690","first-page":"697404","article-title":"Reduced risk of Parkinson's disease in users of calcium channel blockers: a meta-analysis","volume":"2015","author":"Gudala","year":"2015","journal-title":"Int. J. Chronic Dis."},{"key":"10.1016\/j.ceca.2017.06.008_bib0695","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/aje\/kwr362","article-title":"Use of calcium channel blockers and Parkinson's disease","volume":"175","author":"Pasternak","year":"2012","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ceca.2017.06.008_bib0700","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1523\/JNEUROSCI.3010-16.2017","article-title":"Inhibition of L-Type Ca2+ channels by TRPC1-STIM1 complex is essential for the protection of dopaminergic neurons","volume":"37","author":"Sun","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0705","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/abbs\/gmt127","article-title":"TRPC1 protects dopaminergic SH-SY5Y cells from MPP+, salsolinol, and N-methyl-(R)-salsolinol-induced cytotoxicity","volume":"46","author":"Arshad","year":"2014","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.ceca.2017.06.008_bib0710","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.brainres.2006.04.104","article-title":"TRPC1 protects human SH-SY5Y cells against salsolinol-induced cytotoxicity by inhibiting apoptosis","volume":"12","author":"Bollimuntha","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.ceca.2017.06.008_bib0715","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1074\/jbc.M407384200","article-title":"TRPC1-mediated inhibition of 1-methyl-4-phenylpyridinium ion neurotoxicity in human SH-SY5Y neuroblastoma cells","volume":"280","author":"Bollimuntha","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2017.06.008_bib0720","doi-asserted-by":"crossref","first-page":"13784","DOI":"10.1523\/JNEUROSCI.1680-15.2015","article-title":"Store-operated calcium entry through orai is required for transcriptional maturation of the flight circuit in drosophila","volume":"35","author":"Pathak","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ceca.2017.06.008_bib0725","doi-asserted-by":"crossref","first-page":"10332","DOI":"10.1038\/ncomms10332","article-title":"Impairment of PARK14-dependent Ca(2+) signalling is a novel determinant of Parkinson's disease","volume":"7","author":"Zhou","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ceca.2017.06.008_bib0730","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1113\/jphysiol.2008.154997","article-title":"Orai, STIM1 and iPLA(2)\u03b2: a view from a different perspective","volume":"586","author":"Bolotina","year":"2008","journal-title":"J. Physiol."},{"key":"10.1016\/j.ceca.2017.06.008_bib0735","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M606504200","article-title":"Activation mechanism for CRAC current and store-operated Ca2+ entry: calcium influx factor and iPLA2beta \u2013dependent pathway","author":"Csutora","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2017.06.008_bib0740","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-3-319-26974-0_6","article-title":"Phospholipase A2 as a molecular determinant of store-operated calcium entry","volume":"898","author":"Smani","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ceca.2017.06.008_bib0745","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.cell.2006.06.059","article-title":"Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations","volume":"126","author":"Tu","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ceca.2017.06.008_bib0750","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbrc.2012.10.107","article-title":"Calcium leak through ryanodine receptor is involved in neuronal death induced by mutant huntingtin","volume":"429","author":"Suzuki","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ceca.2017.06.008_bib0755","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1523\/JNEUROSCI.1038-15.2016","article-title":"Enhanced store-operated calcium entry leads to striatal synaptic loss in a Huntington's disease mouse model","volume":"36","author":"Wu","year":"2016","journal-title":"J. Neurosci."}],"container-title":["Cell Calcium"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143416017300660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143416017300660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T20:26:17Z","timestamp":1758918377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143416017300660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":151,"alternative-id":["S0143416017300660"],"URL":"https:\/\/doi.org\/10.1016\/j.ceca.2017.06.008","relation":{},"ISSN":["0143-4160"],"issn-type":[{"value":"0143-4160","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calcium signaling and molecular mechanisms underlying neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Cell Calcium","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ceca.2017.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}